Benefit of heparin plus aspirin vs aspirin alone in unstable angina.

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.

Podrobná bibliografie
Hlavní autoři:	Collins, R, Baigent, C, Peto, R
Médium:	Journal article
Jazyk:	English
Vydáno:	1996

Podobné jednotky

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
Autor: Baigent, C, a další
Vydáno: (2001)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
Autor: Collins, R, a další
Vydáno: (1997)

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
Autor: Hunt, D, a další
Vydáno: (1992)

Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report
Autor: Iyad Maqboul, a další
Vydáno: (2024-06-01)

Comparison of Two Therapeutic Protocols : Heparin with Aspirin VS Prednisolone with Aspirin, in Patients with Recurrent Miscarriages
Autor: S. Rabiee, M.D., a další
Vydáno: (2007-01-01)

Immediate aspirin for suspected ischaemic stroke.
Autor: Baigent, C, a další
Vydáno: (1999)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
Autor: Buck, G, a další
Vydáno: (2018)

Aspirin and stroke.
Autor: Buring, J, a další
Vydáno: (1990)

Aspirin in the primary prevention of vascular disease Reply
Autor: Baigent, C, a další
Vydáno: (2009)

Aspirin in the primary prevention of vascular disease Reply
Autor: Baigent, C, a další
Vydáno: (2009)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
Autor: Jigang Chen, a další
Vydáno: (2022-03-01)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
Autor: Shalin Rawal, a další
Vydáno: (2022-06-01)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.
Autor: Shuai Tan, a další
Vydáno: (2015-01-01)

ASPIRIN AND THE STOMACH - REPLY
Autor: Doll, R, a další
Vydáno: (1981)

ASPIRIN USE AND CHRONIC DISEASES
Autor: Hennekens, C, a další
Vydáno: (1990)

Aspirin and transient ischaemic attacks.
Autor: Peto, R, a další
Vydáno: (1979)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
Autor: Patrono, C, a další
Vydáno: (2010)

Variability in aspirin efficacy: all in the genes?
Autor: Baigent, C, a další
Vydáno: (2019)

Aspirin for everyone older than 50? Against.
Autor: Baigent, C
Vydáno: (2005)

Low-dose aspirin for the prevention of atherothrombosis.
Autor: Patrono, C, a další
Vydáno: (2005)

Effect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
Autor: Afsaneh Forood, a další
Vydáno: (2014-01-01)

Aspirin in ischemic heart disease.
Autor: Hennekens, C, a další
Vydáno: (1992)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
Autor: Ying Chen, a další
Vydáno: (2022-04-01)

Role of aspirin in primary prevention of cardiovascular disease
Autor: Patrono, C, a další
Vydáno: (2019)

RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
Autor: Collins, R, a další
Vydáno: (1987)

Aspirin for disease prevention: public policy or personal choice?
Autor: Baigent, C
Vydáno: (2016)

RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
Autor: Collins, R
Vydáno: (1987)

Low-dose aspirin for migraine prophylaxis.
Autor: Buring, J, a další
Vydáno: (1990)

An overview of the British and American aspirin studies.
Autor: Hennekens, C, a další
Vydáno: (1988)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Autor: Mojtaba Khazaei, a další
Vydáno: (2019-03-01)

Critical Overview on the Benefits and Harms of Aspirin
Autor: Chun Shing Kwok, a další
Vydáno: (2010-05-01)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
Autor: Patrono, C, a další
Vydáno: (2005)

Prevention. Aspirin in primary prevention--good news and bad news.
Autor: Hennekens, C, a další
Vydáno: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
Autor: Hennekens, C, a další
Vydáno: (2012)

Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users
Autor: Hyun Seok Lee, a další
Vydáno: (2023-07-01)

Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials
Autor: Lulu Dai, a další
Vydáno: (2022-12-01)

Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
Autor: Giuseppe Camporese, a další
Vydáno: (2023-05-01)

Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
Autor: Giuseppe Camporese, a další
Vydáno: (2023-05-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Autor: Hennekens, C, a další
Vydáno: (1989)

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial
Autor: Wong, K.S.L., a další
Vydáno: (2010)